Qualitek Labs Ltd vs Sheel Biotech Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 18, 2026

Key Highlights

The Latest Trading Price of Qualitek Labs Ltd is ₹ 355 as of 18 Mar 15:30 . The P/E Ratio of Qualitek Labs Ltd is 0 as of March 2021 .The P/E Ratio of Sheel Biotech Ltd is 0 as of March 2021 . The Market Cap of Qualitek Labs Ltd is ₹ 0 crore as of March 2021 .The Market Cap of Sheel Biotech Ltd is ₹ 0 crore as of March 2021 . The Dividend Payout of Qualitek Labs Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Sheel Biotech Ltd changed from 28.46 % on March 2022 to 14.05 % on March 2025 . This represents a CAGR of -16.18% over 4 years .

About Qualitek Labs Ltd

Qualitek Labs Limited was incorporated as 'Qualitek Labs Private Limited' at New Delhi as a Private Limited Company, pursuant to Certificate of Incorporation dated May 17, 2018 issued by Registrar of Companies, New Delhi.
Subsequently, Company was converted into a Public Limited Company and the name of Company was changed to 'Qualitek Labs Limited' vide a Fresh Certificate of Incorporation issued by the Registrar of Companies, New Delhi on April 26, 2023. The Promoters and Directors, Mr Alok Kumar Agarwal, Mr. Kamal Grover and Mr. Antaryami Nayak established the Company for testing, inspection and certification business in year 2018.
Qualitek Labs has a system of internal controls to ensure that all the assets are safeguarded and productive.
Company is engaged in the business of providing Testing, Inspection and Certification services in the fields of Automobiles, Defence, Electronics & Electricals, Pharmaceuticals, Medical Devices, Metals, Minerals, Environment Monitoring, Food, Water etc.

About Sheel Biotech Ltd

Sheel Biotech Limited was incorporated as a Private Company as 'Sheel Biotech Private Limited' dated November 26, 1991, with the Registrar of Companies, Delhi & Haryana.
Further, Company was converted into a Public Limited Company w.e.f.
April 02, 1992. The Company was founded by Dr. Satya Narayan Chandak in 1991.
Thereafter, through his vision he led the stone of Tissue Culture lab wherein for advancement of lab he deputed two of his scientists to Netherlands for training to expand the business ventured in domestic market too and then added greenhouse division to promote protected cultivation.
The Company started the Import division in 2019 and importing tulip, glad, lilium, orchids and alstromeria.

FAQs for the comparison of Qualitek Labs Ltd and Sheel Biotech Ltd

Which company has a larger market capitalization, Qualitek Labs Ltd or Sheel Biotech Ltd?

Market cap of Qualitek Labs Ltd is 413 Cr while Market cap of Sheel Biotech Ltd is 104 Cr

What are the key factors driving the stock performance of Qualitek Labs Ltd and Sheel Biotech Ltd?

The stock performance of Qualitek Labs Ltd and Sheel Biotech Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Qualitek Labs Ltd and Sheel Biotech Ltd?

As of March 18, 2026, the Qualitek Labs Ltd stock price is INR ₹355.0. On the other hand, Sheel Biotech Ltd stock price is INR ₹51.35.

How do dividend payouts of Qualitek Labs Ltd and Sheel Biotech Ltd compare?

To compare the dividend payouts of Qualitek Labs Ltd and Sheel Biotech Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.